1. 2022
  2. Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients

    Haggenburg, S., Lissenberg-Witte, B. I., van Binnendijk, R. S., den Hartog, G., Bhoekhan, M. S., Haverkate, N. J. E., de Rooij, D. M., van Meerloo, J., Cloos, J., Kootstra, N. A., Wouters, D., Weijers, S. S., van Leeuwen, E. M. M., Bontkes, H. J., Tonouh-Aajoud, S., Heemskerk, M. H. M., Sanders, R. W., Roelandse-Koop, E., Hofsink, Q., Groen, K. & 28 others, Çetinel, L., Schellekens, L., den Hartog, Y. M., Toussaint, B., Kant, I. M. J., Graas, T., de Pater, E., Dik, W. A., Engel, M. D., Pierie, C. R. N., Janssen, S. R., van Dijkman, E., Poniman, M., Burger, J. A., Bouhuijs, J. H., Smits, G., Rots, N. Y., Zweegman, S., Kater, A. P., van Meerten, T., Mutsaers, P. G. N. J., van Doesum, J. A., Broers, A. E. C., van Gils, M. J., Goorhuis, A., Rutten, C. E., Hazenberg, M. D. & Nijhof, I. S., 8 Mar 2022, In: Blood advances. 6, 5, p. 1537-1546 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Antibody Response in Immunocompromised Patients with Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19

    Haggenburg, S., Hofsink, Q., Lissenberg-Witte, B. I., Broers, A. E. C., van Doesum, J. A., van Binnendijk, R. S., den Hartog, G., Bhoekhan, M. S., Haverkate, N. J. E., Burger, J. A., Bouhuijs, J. H., Smits, G. P., Wouters, D., van Leeuwen, E. M. M., Bontkes, H. J., Kootstra, N. A., Zweegman, S., Kater, A. P., Heemskerk, M. H. M., Groen, K. & 8 others, van Meerten, T., Mutsaers, P. G. N. J., Beaumont, T., van Gils, M. J., Goorhuis, A., Rutten, C. E., Hazenberg, M. D. & Nijhof, I. S., 2022, (E-pub ahead of print) In: JAMA oncology.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. SARS-CoV-2 hyperimmune globulin for severely immunocompromised patients with COVID-19: a randomised, controlled, double-blind, phase 3 trial

    Huygens, S., Hofsink, Q., Nijhof, I. S., Goorhuis, A., Kater, A. P., te Boekhorst, P. A., Swaneveld, F., Novotny, V. M., Bogers, S., Welkers, M. R., Papageorgiou, G., Rijnders, B. J., Heijmans, J. & Heijmans, J., 2022.

    Research output: Working paperPreprint

  5. 2020
  6. The value of sorafenib trough levels in patients with advanced hepatocellular carcinoma–a substudy of the SORAMIC trial

    Labeur, T. A., Hofsink, Q., Takkenberg, R. B., van Delden, O. M., Mathôt, R. A. A., Schinner, R., Malfertheiner, P., Amthauer, H., Schütte, K., Basu, B., Kuhl, C., Mayerle, J., Ricke, J. & Klümpen, H-J., 1 Sep 2020, In: Acta Oncologica. 59, 9, p. 1028-1035 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. 2018
  8. Post-hepatectomy liver regeneration in the context of bile acid homeostasis and the gut-liver signaling axis

    de Haan, L., van der Lely, S. J., Warps, A-L. K., Hofsink, Q., Olthof, P. B., de Keijzer, M. J., Lionarons, D. A., Mendes-Dias, L., Bruinsma, B. G., Uygun, K., Jaeschke, H., Farrell, G. C., Teoh, N., van Golen, R. F., Li, T. & Heger, M., 28 May 2018, In: Journal of clinical and translational research. 4, 1, p. 1-46 46 p.

    Research output: Contribution to journalArticleAcademicpeer-review

ID: 6062343